Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, 89081 Ulm, Germany.
Institute of Clinical and Experimental Trauma-Immunology, University Hospital, 89081 Ulm, Germany.
J Immunol. 2019 Apr 1;202(7):2082-2094. doi: 10.4049/jimmunol.1801545. Epub 2019 Feb 11.
The plasma proteins Factor H (FH) and its alternate splice variant FH-like protein 1 (FHL-1) are the major regulators of the complement alternative pathway. The indiscriminate nature of alternative pathway activation necessitates the regulators to be host selective, but the underlying principles of selectivity remained largely elusive. By analyzing human FH and FHL-1 for protection of different host and foreign cells (rabbit and yeast), we uncovered a 2-fold discriminatory mechanism of FH in favor of self: relative to FHL-1, FH exhibits a regulatory benefit on self but importantly, also, a regulatory penalty on nonself surfaces, yielding a selectivity factor of ∼2.4 for sialylated host surfaces. We further show that FHL-1 possesses higher regulatory activity than known but is relatively unselective. The reason for this unexpected high activity of FHL-1 is the observation that the complement regulatory site in FH exceeds the established first four domains. Affinity for C3b, cofactor and decay-accelerating activities, and serum assays demonstrate that the regulatory site extends domains 1-4 and includes domains 5-7. But unlike FH, FHL-1 exhibits a fast plasma clearance in mice, occurs sparsely in human plasma (at one fortieth of the FH concentration), and resists deregulation by FH-related proteins. These physiological differences and its late phylogenetic occurrence argue that FHL-1 is crucial for local rather than systemic compartments. In conclusion, we demonstrate a 2-fold discriminatory power of FH to promote selectivity for self over foreign and show that FHL-1 is more active than known but specialized for regulation on local tissues.
血浆蛋白因子 H(FH)及其交替剪接变体 FH 样蛋白 1(FHL-1)是补体替代途径的主要调节剂。替代途径激活的无差别性质需要调节剂具有宿主选择性,但选择性的基本原理在很大程度上仍然难以捉摸。通过分析人类 FH 和 FHL-1 对不同宿主和外来细胞(兔和酵母)的保护作用,我们发现了 FH 有利于自身的 2 倍区分机制:与 FHL-1 相比,FH 对自身表现出调节优势,但重要的是,对非自身表面也表现出调节劣势,产生了对唾液酸化宿主表面的选择性因子约为 2.4。我们进一步表明,FHL-1 具有比已知的更高的调节活性,但相对不具有选择性。FHL-1 具有这种出乎意料的高活性的原因是观察到 FH 中的补体调节位点超过了公认的前四个结构域。对 C3b 的亲和力、辅助因子和衰变加速活性以及血清测定表明,调节位点延伸到结构域 1-4,并包括结构域 5-7。但与 FH 不同,FHL-1 在小鼠中表现出快速的血浆清除,在人类血浆中(仅为 FH 浓度的四十分之一)出现稀疏,并抵抗 FH 相关蛋白的去调节。这些生理差异及其在系统发生上的后期出现表明,FHL-1 对于局部而非全身隔室至关重要。总之,我们证明了 FH 具有 2 倍的区分能力,以促进自身对外国的选择性,并表明 FHL-1 比已知的更活跃,但专门用于局部组织的调节。